Columbia University

Technology Ventures

Latest News

  • J&J says it will buy Auris Health for $3.4 billion.
  • The purchase gives J&J an entry into robotics.
  • It also builds on the company's partnership with Alphabet's Verily.

Fortress-founded Caelum Biosciences to receive $60 million in a strategic equity investment and option fee

Alexion has option to acquire Caelum Biosciences based on Phase 2 data

[Editor’s Note: Euan Robertson, the Director of Strategic Planning & Special Projects at Columbia Technology Ventures, co-wrote this article.] It is a commonly held belief that academic research institutions, including those in New York City, are fierce competitors.